homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

July 23, 2019

Immusoft

Seattle-based biopharmaceutical company Immusoft appointed Dr. Robert Hayes as chief scientific officer. Hayes has nearly two decades of biologics discovery and development experience, most recently as head of biologics at Amgen. Prior to that, he was vice president and venture leader at Centyrex, a biotech venture within Janssen R&D. Immusoft re-engineers B cells to treat diseases.




Email or user name:
Password:
 
Forgot password? Click here.